Table 2.
Serum levels of total IGF-1, serum free IGF-1, IGFBP3, adiponectin, leptin, and resistin at baseline, and change (∆) at posttest after resistance exercise
| All patients | Lean | Overweight | Obese | Intergroup differences in change | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | ∆Posttest | Baseline | ∆Posttest | Baseline | ∆Posttest | Baseline | ∆Posttest | Lean vs overweight | Lean vs obese | Overweight vs obese | |
| Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) |
Median (IQR) | Median (IQR) | Median (IQR) | ||||
| Cohen’s d | Cohen’s d | Cohen’s d | Cohen’s d | ||||||||
| P-valuea | P-valuea | P-valuea | P-valuea | P-valueb | P-valueb | P-valueb | |||||
| Total IGF-1 | 137 (54) | −3 (−21.2 to 5) | 135 (54) | −11 (−18,8 to 5) | 151 (61) | −3 (−47,5 to 7) | 137 (61) | −1.5 (−18 to 8,8) | |||
| (ng/ml) | n = 42 | n = 42 | n = 18 | n = 18 | n = 16 | n = 16 | n = 8 | n = 8 | |||
| −0.23 | −0.2 | −0.36 | −0.09 | ||||||||
| 0.018 | p = 0.076 | p = 0.147 | p = 0.528 | p = 0.986 | p = 0.531 | p = 0.528 | |||||
| Free IGF-1 | 2.6 (3.2) | 0 (−1.4 to 1.0) | 3.3 (2.3) | −0.7 (−1,9 to 0,1) | 2.6 (3.3) | 0.4 (−1,1 to 1,5) | 0.8 (2.3) | 0.4 (−0,6 to 2,8) | |||
| (ng/ml) | n = 43 | n = 43 | n = 18 | n = 18 | n = 17 | n = 17 | n = 8 | n = 8 | |||
| −0.05 | −0.32 | 0.1 | 0.6 | ||||||||
| 0.752 | p = 0.047 | p = 0.485 | p = 0.237 | p = 0.053 | p = 0.035 | p = 0.511 | |||||
| IGFBP3 | 823 (159) | −46.4 (−84.4 to 33.2) | 828 (86) | −56 (−97 to 5) | 790 (161) | −47 (−86 to 119) | 858 (238) | −41 (−73 to 23) | |||
| (ng/ml) | n = 43 | n = 43 | n = 18 | n = 18 | n = 17 | n = 17 | n = 8 | n = 8 | |||
| −0.29 | −0.57 | 0.02 | −0.36 | ||||||||
| p = 0.045 | p = 0.025 | p = 0.943 | p = 0.161 | p = 0.335 | p = 0.567 | p = 0.887 | |||||
| Adiponectin | 10288 (6280) | 192 (−1880 to 2064) | 12036 (7396) | 224 (−1638 to 2406) | 11624 (5668) | −832 (−1948 to 1752) | 6600 (4020) | −204 (−2648 to 2398) | |||
| (ng/ml) | n = 43 | n = 43 | n = 18 | n = 18 | n = 17 | n = 17 | n = 8 | n = 8 | |||
| 0.02 | 0.09 | −0.03 | −0.04 | ||||||||
| 0.819 | p = 0.586 | p = 0.813 | p = 0.889 | p = 0.59 | p = 0.765 | p = 0.887 | |||||
| Leptin | 27.7 (71.6) | −4.9 (−18.5 to 1.0) | 21 (86) | −15.9 (−23,6 to −0,1) | 39 (60) | 0 (−3 to 19,6) | 23 (106) | −12 (−23,1 to −2,3) | |||
| (ng/ml) | n = 43 | n = 43 | n = 18 | n = 18 | n = 17 | n = 17 | n = 8 | n = 8 | |||
| −0.13 | −0.22 | −0.02 | −0.51 | ||||||||
| 0.040 | p = 0.008 | p = 0.463 | p = 0.093 | p = 0.005 | p = 0.849 | p = 0.019 | |||||
| Resistin | 13.1 (5.1) | −0.7 (−2.0 to 0.9) | 13 (5) | −0.7 (−1.5 to 1) | 11 (7) | 0.2 (−2,5 to 1,6) | 15 (5) | −1.6 (−1,9 to 0,1) | |||
| (ng/ml) | n = 43 | n = 43 | n = 18 | n = 18 | n = 17 | n = 17 | n = 8 | n = 8 | |||
| −0.11 | 0.04 | −0.19 | −0.42 | ||||||||
| 0.227 | p = 0.446 | p = 0.723 | p = 0.161 | p = 0.987 | p = 0.285 | p = 0.588 | |||||
Serum levels of the whole group and subdivided in lean, overweight and obese patients. Median values, upper and lower boundaries of the interquartile (IQR) range are indicated. Effect size of change is shown as Cohen’s d. Within group comparisons (p-valuea: Wilcoxon signed rank test) and group comparisons (p-valueb: Mann–Whitney U-test) are shown. P-values in bold type are significant